Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v6-EN
Language French English
Date Updated 2021-06-04 2021-06-04
Drug Identification Number Not Applicable/non applicable Not Applicable/non applicable
Brand name THALLOUS CHLORIDE TI 201 INJECTION THALLOUS CHLORIDE TI 201 INJECTION
Common or Proper name Thallous Chloride TI 201 Injection Thallous Chloride TI 201 Injection
Company Name GE HEALTHCARE CANADA INC GE HEALTHCARE CANADA INC
Ingredients THALLIUM CHLORIDE THALLIUM CHLORIDE
Strength(s) 37MBq 37MBq
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 mL 10 mL
ATC code V09GX V09GX
ATC description
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-06-04 2021-06-04
Actual discontinuation date 2021-06-04 2021-06-04
Remaining supply date 2021-06-04 2021-06-04
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments